Webvent

SCRS Sites Directory

Search SCRS member sites. Discover current trials.

P3 Research Ltd

P3 Research is a leading and respected independent clinical trials company in New Zealand

P3 Research Ltd

P3 Research is a leading and respected independent clinical trials company in New Zealand. For more than 20 years, our sites have gained a strong reputation for conducting high-quality studies, ranging from small-scale Phase 1b and 2 trials to larger, longer-term Phase 3 trials.

P3 Research owns and operates several locations throughout New Zealand, allowing us to conduct trials on different demographics and locations. With over 20 years of experience, we have established a large and reliable database of pre-screened candidates, enabling us to recruit participants more efficiently.

We have experience performing studies in a wide range of therapeutic areas, including:

  • Vaccine development
  • Diabetes/metabolic
  • Weight Loss
  • Dermatology
  • Respiratory
  • Coeliac Disease / IBS
  • Osteoarthritis
  • Cardiovascular
  • Migraine
  • Other prevalent conditions
  • PK studies

P3 Research offers centralised support and team collaboration across all P3 Units, which include:

  • Single point contact for feasibilities.
  • Dedicated Start-up team for all study start-up matters.
  • Regulatory team for P3 Network.
  • Frequent involvement as the lead site for New Zealand

Single point contact for contract and budget negotiations for all P3 Research sites.

  • Administration and IT team overseeing RealTime CTMS and eSource.
  • Marketing and recruitment team for advertising and oversight of our databases.
  • Extensive SOPs and QA procedures. 

Information

Demographic Data

  • SITE INFORMATION 
  • Start year clinical research2001
  • Phases of clinical studiesPhase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Vaccines
  • PopulationsChild 2-10 yrs, Adolescent 11-17 yrs, Adult 18-64 yrs, Senior 65 yrs and over
  • SPECIFIC SITE INFORMATION 
  • Type of siteFreestanding
  • # of employees involved in research500+ (across seven sites in NZ)
  • # of investigators14+
  • Number of studies last year30+ (seven sites in NZ)
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday
  • Extended office hoursYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL, Other
  • REGULATORY INFORMATION 
  • Contact for regulatory documentsKatie Kennett
  • Regulatory phone number64 29 200 1116
  • # of days to turn around regulatory documentsFor initial submission around 2 weeks
  • Type of IRB used by this siteCentral
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • FINANCIAL INFORMATION 
  • # days to turn around budget and contract14 days